| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07290257 | Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli® in… | Alagille Syndrome | Recruiting |
| Phase 3 | |||
| NCT07200908 | A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic… | Chronic Hepatitis D Infection | Recruiting |
| NCT07298330 | A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis… | Chronic Hepatitis D Infection | Active, Not Recruiting |
| NCT06553768 | Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease… | Cholestatic Liver Disease (Except ALGS, PFIC, PBC and PSC) | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT07454837 | Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants… | Chronic Hepatitis D | Recruiting |
| NCT06907290 | A Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis… | Chronic Hepatitis D Infection | Active, Not Recruiting |
| Phase 2 | |||
| NCT05050136 | A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in… | Primary Biliary Cholangitis | Recruiting |
| NCT07209462 | Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM) | Fragile X Syndrome | Recruiting |
| NCT04663308 | A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in… | Primary Sclerosing Cholangitis | Active, Not Recruiting |
| Phase 1 | |||
| NCT07712718 | A Study to Evaluate the Absorption, Distribution, Metabolism, and Excretion of… | Healthy Volunteers | Recruiting |
| Not specified | |||
| NCT06193928 | Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States… | Alagille Syndrome | Recruiting |
| NCT03115086 | The REPLACE Registry for Cholbam® (Cholic Acid) | Bile Acid Synthesis Disorders | Active, Not Recruiting |